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Summary This study has examinied cells from naturally-occurring murine mammary tumours to ascertain
whether cell surface glycoproteins play a significant role in colonisation of the lungs after intravenous
inoculation. It was found that gel electrophoretic analysis of membrane extracts and lectin adsorption studies
(ild inot reve;fl anv consistent differences in dlvconrotein composition of cells from tumours which can heavily
colonise the lungs relative to ones from tumours which . innot do so or to cells from pulmonary metastases.
Also, alteration of structural and functional properties of surface glycoproteins by treatment with succinylated
lectins or with drugs such as tunicamycin and swainsonine, which inhibit glycosylation of membrane proteins,
had no specific effects on metastatic colonisation of the lungs. Tunicamycin apparently decreased capability to
form experimental metastases but also diminished tumourigenicity on subcutaneous inoculation, although it
did not affect tumour cell viability in vitro.
This information supports earlier studies from this laboratory involving enzymic digestion of the surface of
living tumour cells before inoculation and demonstrates that the pulmonary colonisation capability of these
mammary tumour cells can withstand global disorganisation of membrane glycoprotein structure and
composition. This implies that either the surface glycoproteins are not important in the colonisation process,
or that these tumour cells have great capability for rapid repair of their surfaces. It is concluded that a clear
answer to whether surface glycoprotein composition has a decisive role in pulmonary colonisation by these
mammary tumour cells requires introduction of stable heritable traits into tumour cell populations by genetic
manipulation.
The purpose of this investigation was to try to test directly
whether glycosylated constituents of the cell surface play a
significant part in metastatic colonisation of distant sites by
disseminating tumour cells from naturally-occurringt (i.e.
not transplanted) murine mammary tumours. Numerous
publications have reported associations between the
glycoprotein composition of the cell surface and metastatic
behaviour (see Nicolson, 1982 for review) but very few have
explored whether direct perturbation of the glycosylation
patterns of surface molecules could demonstrate causal
involvement in success or failure of the metastatic process.
The most cogent evidence that the surface g!ycoprotein
composition of tumour cells affects their metastatic
capability has been provided by the work of Irimura et al.
(1981), Kerbel et al. (1983), Larizza and Schirrmacher
(1984), Olsson and Forchhammer (1984) and Humphries et
al. (1986). All these groups observed alterations in capability
to make metastatic tumour colonies in distant organs
following procedures which concomitantly altered surface
glycoprotein composition. 1rimura et al. (1981) used
tunicamycin, an antibiotic which blocks glycosylation of
proteins and lipids and Humphries et al. (1986) used
swainsonine which also affects glycosylation but at a
different stage. Olsson and Forchhammer (1984) used 5-
azacytidine which alters DNA methylation and hence gene
expression and showed the appearance of a novel cell surface
protein, whilst Kerbel et al. (1983) and Tao and Burger
(1977, 1982) obtained cells with altered metastatic capability
using in vitro selection for resistance to lectin toxicity and
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tThese tumours are caused by the murine mammary tumour virus
(MMTV) and are referred to as naturally-occurring in this
communiication because they arise without the intervention of the
investigator.
Larizza and Schirrmacher (1984) fused non-metastatic
lymphoma cells with macrophages. The issue remains that
none of these experimental procedures can be confidently
assumed to have specific effects on the metastatic process
sole// via effects on the surface glycoprotein composition.
Corroboration of this attractive hypothesis therefore requires
converging lines of evidence from several experiments of
different design on diverse tumour types.
The experiments described in this communication were
performed to test whether direct perturbation of cell surface
composition of cells from naturally-occurring murine
mammary tumour would alter or interfere with their
capability to colonise the lung which is their preferred site of
metastasis.
Materials and methods
Animals and tumlour-s
Primary and metastatic tumours were obtained from
C3H/AvY mice endemically infected with the murine
mammary tumour virus. Assays for metastatic potential were
conducted in virus-free syngeneic animals of the same age
and sex (see Tarin & Price, 1979, for details).
Cells tand initiastatic coloni:ation assavs
Cells were aseptically obtained from primary murine
mammary tumours growing in mice of the C3H/AVY strain.
The tumours were finely minced with scalpels and incubated
with collagenase, I mgmli-, in modified Eagle's medium
(MEM) at 37 C for 2h with constant agitation. Cells were
kept free from any exogenous protein (e.g. bovine serum)
throughout their preparation. At the end of this time, tissue
clumps were allowed to settle under unit gravity and the
supernatant collected (Tarin & Price, 1979). Suspended cells
were washed once in MEM, resuspended in MEM and
layered over isotonic Nycodenz [Nyegaard and Co., Oslo],
diluted with MEM to give a density of 1.09gml- 1. The
interface was gently stirred to produce a short gradient and
this was centrifuged for 20min at 1800g. Cells at the
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interface were collected, the procedure repeated and the
tumour cells (now purified from erythrocytes and cell debris)
were washed and suspended in MEM and kept on ice. An
aliquot was stained with ethidium bromide and fluorescein
diacetate and counted in a haemocytometer to assess total
cell count and percentage viability (Price & Tarin, 1982).
When cells from pulmonary secondary deposits arising
from i.v. inoculation of primary mammary tumour cells were
studied, tumour nodules were carefully dissected free from
lung tissue dissociated with collagenase and treated exactly
as above.
The primary mammary tumour cells were assayed for their
pulmonary metastatic colonization potential by i.v. inocu-
lation of 5x 105 viable cells in MEM into groups of 5-6
syngeneic MMTV-free female C3H/AVY mice under direct
vision, following surgical exposure of one lateral tail vein of
the mouse under methoxyflurane (Penthrane) anaesthesia.
The mice were killed and autopsied 3 months later, or
sooner if moribund, and the degree of pulmonary
colonisation graded on a semi-quantitative scale (Table I) as
previously described by Tarin and Price (1979). Lungs
showing no surface evidence of tumour colonization were
examined histopathologically to look for deeper deposits.
Extrapulmonary lesions and any pulmonary foci not having
the characteristic appearance of secondary mammary tumour
deposits were also processed for histological examination.
Table I Scale for grading the colonisation potential of
primary MMTVs
Number ofsecondary
colonies seen on the
surface ofthe lungs Grade
19 Low colonisation
10-29 2 J potential
30-49 3 High colonisation >5100
99 Jpotential
Extraction ofcell membranes with Nonidet-P40
Disaggregated tumour cells were centrifuged at 30g for
15min, and the pellets resuspended in ice-cold 0.15 MNaCI,
10 mM EDTA, 20 mm Tris, pH 7.4. The cells were then
immediately re-pelleted by centrifugation and resuspended in
fresh buffer. This suspension was then adjusted to (final
concentrations) 0.5% Nonidet-P40, mmPMSF and 0.04%
NaN3; approximately 200p1 0.5% NP40/107 cells. This was
vortexed vigorously at room temperature for
- 10 sec at 0, 5,
10 and 15 min to disrupt cells and solubilise their membranes
and then centrifuged for 5min in a Beckman microfuge B.
The supernatants were stored in aliquots in liquid nitrogen
with one aliquot being kept at -20°C (for subsequent
Lowry protein estimation). The nuclear pellets were fixed in
buffered isotonic formaldehyde and processed for histo-
pathological examination to confirm effective solubilisation
of cell membranes.
Protein estimation
The protein contents of solutions were determined by the
method of Lowry et al. (1951), using the above lysis buffer
as blank, with bovine serum albumin fraction V as standard.
Absorbance was measured at 715 nm in a Pye Unicam
SP1800 spectrophotometer.
One dimensional electrophoresis
Resolving slab gels were made of a linear 5-20% gradient of
polyacrylamide, pH 8.8 (Trizma pre-set pH crystals), using a
Pharmacia gradient mixer, with a 4% acrylamide stacking
gel, pH 6.8. The running buffer was Tris-glycine-SDS,
pH 8.8.
Samples were prepared by boiling in 2% SDS and 5% ,B-
mercaptoethanol for 3min before being loaded onto the gel
(50pg protein per lane) and run through the stacking gel at
35mA/gel then at 50mA/gel through the resolving gel.
Bromophenol blue was used as a tracking dye and was run
just off the end of the gels which were then fixed in 50%
methanol overnight before being stained with silver
according to the method of Wray et al. (1981).
Two dimensional electrophoresis
Rod gels of 2.7 x 60mm were made consisting of 9M urea,
4% Nonidet-P40, 2% ampholyte, pH 3-10 (Pharmalyte) in a
4% polyacrylamide gel. The cathode was 0.1 MNaOH and
the anode 0.1%H3PO4. Samples were boiled in SDS and /3-
mercaptoethanol for 3min. SDS was then displaced with a
10 x excess of Nonidet P-40 (Ames & Nikaido, 1976) and
25pg protein in 75pl was loaded per gel, overlayered with
20pl dilute sample buffer and electrophoresed at 400V for
17h. Rod gels were then equilibrated in 20% /3-
mercaptoethanol, 4% SDS, pH 6.8 for 70min at room
temperature and stored at -20°C until electrophoresis in the
second dimension. For this they were thawed and fused to
the stacking gel of gels made exactly as described above,
using hot 2% agarose with 0.1% SDS, pH 6.8 containing
bromophenol blue as a tracking dye.
Protein 125I-iodination, immobilized-lectin adsorption and
autoradiography ofNonidet-P40 extract
The NP-40 extracts described above were adjusted to 2mg
proteinml - in 0.7ml (i.e. 1.4mg protein). This solution was
made to 80% in ethanol with a few drops of saturated
sodium acetate in ethanol added (to improve flocculation).
This was mixed and kept at - 20"C for - 50h. The
precipitate was pelleted by centrifugation at 1800g for
20min, washed once with 3ml ethanol, vacuum dried and
solubilised in 0.5ml 50mM PBS containing 2%SDS, pH7.0
at 65°C for 2 h. Proteins were iodinated in this buffer at
room temperature for 20min using 150pCiNa 1251 per tube
and the solid state reagent lodo-beads, I bead per tube for
the primary tumour extracts, 4 beads/tube for lung
secondary extracts (Markwell, 1982). The cells from
metastases yielded less protein and were therefore incubated
with more beads to increase specific activity of labelling and
improve sensitivity of detection. (This is a chemical, not
enzymic, iodination reagent consisting of N-chloro-
benzenesulphonamide, sodium salt, covalently attached to
nonporous polystyrene beads). The samples were then kept
on ice until being chromatographed through disposable mini-
columns of Sephadex G-25M, equilibrated and developed in
10mM Tris. buffered saline, pH 7.4 containing 0.5% v/v
Nonidet-P40 and 0.04% NaN3. Material emerging in the
void volume was collected and kept on ice.
Agarose-bound lectins (Eli Lilly, Windlesham, Surrey)
were prepared by repeated washing in this buffer with the
modification that, after removal of the phosphate buffer in
which most lectins were stored, agarose-Con A was
equilibrated with buffer +2mm CaCI2 +2mm MnCl2 and
agarose-WGA with buffer + 2mm CaCI + 2mm MnCI2 +
2mM ZnCl2.
All 5 lectins were distributed into tubes in aliquots of
200 l and equal amounts of 1251-labelled protein extracts
added to them again in 200,p1 volumes. This was incubated
at 4"C overnight and for 2 h at room temperature, with
shaking. Bound material was then pelleted by centrifugation
at 1800g for 5min and this was washed with 3 x 2.5ml ice
cold buffer (with 1 mMCa2 , Mn2 ,Zn2 as above). The
lectin gels were then resuspended in 0.5ml buffer containing
the appropriate sugar specifically bound by each lectin as
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Con A: 0.1 M methyl-D-mannoside (MDM) in buffer+
1 mMCaCl2 +'mMMnCl2
DBA: 0.1 M N-acetyl-D-galactosamine in buffer
RCA 1: 0.2 M D( +)-galactose in buffer
UEA 1: 0.2M L(-) fucose in buffer
WGA: 0.2M N-acetyl D-glucosamine (gle NAC) in buffer +
I mMCaCl2 + 'mMMnCl2+1 mMZnCl2.
This incubation was for 30 min at room temperature
followed by an overnight incubation at 4"C with double the
above concentrations of sugars. The supernatants from these
two incubations were pooled, 100,ug bovine serum albumin
fraction V was added to each as a carrier and they were
adjusted to 80% in ethanol plus a few drops of saturated
sodium acetate in ethanol at -20"C for 3 days. The
precipitate was pelleted by centrifugation and electro-
phoresed as described above.
Gels were either fixed in 50% methanol overnight and re-
expanded in water or immediately subjected to
autoradiography by blotting the gels free of surface water,
covering them with a thin plastic sheet (Alcan wrap,
thickness - 12pm) and exposing the gels to pre-flashed
Kodak X-Omat RP film at -70"C with an intensifying
screen (Laskey & Mills, 1977).
Studies on ejfiwts of succinylated ConA and WGA on
behaviour of tumour cells
Doubly succinylated ConA and WGA were obtained from
E-Y Laboratories Inc., PO Box 1787, San Mateo, CA94401,
USA. For the purposes of preliminary binding studies they
were iodinated with 125 (Amersham International) in 40mM
phosphate buffered saline, pH 7.0, in the presence of either
0.2 M methyl-D-mannoside (s-ConA) or 0.2 MN-acetyl-D-
glucosamine (s-WGA) to which was added Na 1251 and 3
'iodobeads'. After 20 min at room temperature the beads
were removed and the lectins chromatographed through
columns (PD-I,l Pharmacia) of Sephadex G-25M, pre-
equilibrated and developed with MEM. The specific activities
of the iodinated succinylated lectins were determined by
counting the activity of samples in a gamma counter and
relating this to the protein concentration of the samples,
estimated by the Lowry method, using BSA fraction V as a
standard. MEM served as the blank.
Binding studies were undertaken to estimate the optimum
concentrations and times of exposure of the s-lectins to
tumour cells. Aliquots of 106 cells in lOOpl serum-free
medium (MEM) were distributed into LP3 tubes (coated in
BSA to prevent adsorption of s-lectins to the plastic)
standing on ice. These assays were each performed in
duplicate. 1251-s-ConA or 1251-s-WGA were added to the
tubes in amounts of 5, 10, 20, 50, 100 or 250 pg either:
(i) alone (total uptake)
(ii) in the presence of 0.1 M-methyl-D-mannoside (s-
ConA) or 0.1 MN-acetyl-D-glucosamine (s-WGA)
(non-specific uptake) or
(iii) alone for the period of incubation of (i) then
incubated with 0.1 M MDM or 0.1 M gl NAc for
15 min (non-releasable uptake).
The total volume in all the tubes was 0.4 ml. Tubes were
then incubated for I h at room temperature with occasional
shaking; they were washed 3 times with chilled MEM (the
washings of (ii) and (iii) included 0.1 M MDM or
0.1 M gicNAc) and the activity of the cell pellet was
measured in a gamma counter from which the amount of
s-lectin bound per 106 cells could be calculated.
To measure the rate of s-lectin binding, 106 cells were
again aliquoted into duplicate albuminized LP3 tubes on ice
and 50pg s-lectin added. The cells were incubated with
shaking at room temperature and at appropriate times tubes
were removed, the cells washed and activity counted. Only
total binding was considered in this experiment.
For the treatment of tumour cells with s-lectins prior to
inoculation, 2 x 106 cells in 0.8ml serum-free medium
containing 500,pgs-lectin were incubated for 90min at room
temperature then overnight at 0°C for 16h, washed 3 times
and suspended in medium containing 10% newborn calf
serum. Cell numbers and viability were counted and the
volume of medium adjusted to 106 viable cellsml-'. Control
cells were treated identically except for the absence of lectin.
The effects of s-lectins on pulmonary colonisation
potential were studied for 10 separate primary tumours.
These had different colonisation potentials (assessed before
lectin treatment) ranging from grade 0 to grade 5).
One hundred p1 (i.e. 105 cells) of the appropriate cell
suspension was injected intravenously into the lateral tail
veins of groups of 6 mice.
Studies ofefJects ofswainsonine and tunicamjcin on behaviour
oflive tumour cells
Swainsonine (gift of Dr P. Dorling) was dissolved in ethanol
and stored at -20°C. Tunicamycin (Sigma Chemical Co.,
London) was dissolved in 20 mmNaOH and stored at
-20"C.
To confirm that, under the conditions we employed, these
two compounds had effects on the glycoprotein composition
of the plasma membrane, 106 ml- 1 cells prepared as
described above were cultured at 37"C, 5% C02/95% air for
40h in MEM + 10% NCS in plastic tissue culture flasks in
the presence of either swainsonine, 1 pgml -I (final ethanol
conc. =0.1% v/v) or tunicamycin, 1 pgml-1 (final NaOH
conc. =4mM). Control flasks contained the same concen-
trations of solvents.
After this time floating cells (tunicamycin treatment led to
the cells losing their ability to adhere to plastic) and cells still
attached to plastic were thoroughly washed with cold PBS
and then lysed with 0.5% v/v Nonidet-P40 in PBS containing
1 mM phenylmethylsulphonyl fluoride and 0.04% NaN3'The
protein in this lysate was precipitated with acetone for 40h
at -20"C with 50pgBAS as a carrier. This was pelleted by
centrifugation and dissolved in electrophoresis sample buffer
(2% SDS and 5% mercaptoethanol) at 100"C. The samples
were run in a 10% polyacrylamide resolving gel with a 5%
stacking gel, exactly equal (50,pg) quantities of total protein
extract being applied to each track of the gel. The gel was
then electroblotted on to Schleicher and Schuell nitro-
cellulose paper, pore size 0.45 pm, using a current of 200mA
for 5 h. The paper was blocked with 1% w/v BSA fraction V
in PBS overnight and later the paper was washed in Tris
buffered saline and incubated overnight in TBS containing
1251-ConA in the presence of Ca2+ and Mn2 . It was again
washed exhaustively in TBS, dried and placed in contact
with Kodak X-Omat RP film for several hours, which was
then developed.
To determine the effect that swainsonine and tunicamycin
have on the colonization potentials of MMT cells, batches of
cells were treated with either of the 2 compounds as
described earlier in this section. After the 40-h incubation the
culture medium was aspirated and kept on ice. Adherent
cells were washed twice with Ca2 + and Mg2 + free Earles
balanced salt solution and then incubated at 37"C in this
solution containing 2 mm EGTA for 30 min, after which they
were removed with a rubber policeman and pooled, together
with the 2 washings, with the culture medium at 0°C. They
were then dispersed by gentle trituration with a Pasteur
pipette to produce a monocellular suspension. Trypsin or
other proteases were not used for detachment of cells from
the substratum for studies on colonisation potential or
tumourigenicity because we wished to avoid alteration and
breakdown of surface glycoproteins by these enzymes.
The cells from drug-treated and control groups were
washed 3 times at 0"C with MEM + 10% NCS and their
numbers and viabilities counted. The cell concentration in
each suspension was adjusted to 106 viable cells ml-1 and
0.1 ml (i.e. 105 cells) was injected i.v. into the lateral tail24 N.S.E. SARGENT et ail.
veins of groups of 6C3H/AvYMMTV-free female mice aged
4-6 months using 27G needles.
To examine whether these glycosylation inhibiting agents
had any effects on tumourigenicity, as distinct from
pulmonary colonisation potential, graded doses (103, 104 and
105) of treated and control cells were injected into the
mammary fat pads of batches of syngeneic mice, which were
then observed weekly for tumour formation up to a
maximum of 3 months, at which time all remaining animals
were killed and autopsied.
The ability of the cells to recover from swainsonine or
tunicamycin treatment was also tested in 4itro by incubating
MMT cells from 2 tumours with these agents for periods of
16 or 40 h, then trypsinizing them, washing, and replating
the cells on plastic. Each dish was seeded with 2 x 106
tumour cells and left undisturbed for 3 days before being
removed from the plastic by 0.05% trypsin and 2 mmEGTA
in Ca2 + and Mg2 + free Earles balanced salt solution for
counting total viable cell number (i.e. both floating and
attached cells) and assessing percentage viability.
Results
OnIe- a(In tito-diiensional electroplhoresis and lectin
adsor-ptioni of 1 25I-iodinated NP-40 extract
There were no consistent differences between the protein
profiles of NP-40 extracted MMT cells having high
colonisation potential and those with low colonisation
potential in one- or two-dimensional gels nor in the
autoradiographs of 125I-glycoproteins specifically adsorbed
with 5 different immobilized lectins from the tumour cells
extracts.
The gels and autoradiographs were carefully examined
visually and, in addition, the photographs of gels and some
of the original gels were scanned with a Joyce-Loebl
Chromoscan 3 scanning densitometer. The very sensitive
silver stain was used in preference to Coomassie blue to
detect proteins in gels and 5-20% linear gradient gels were
used, the better to fractionate the proteins. In all, 20 primary
tumours having a range of colonization potentials from
grade 0-5 were examined in this way (Table II) but no
significant or consistent differences were detected between
tumours of high and ones of low colonisation potential
(Figure 1). Also, the secondary lung tumours from four of
the more highly colonizing primaries showed no differences
Table 11 Colonisation grades of tumours used for
one- and two-dimensional electrophoresis and
lectin adsorption
TumIour' 110.
501
511
517
521
528
530
531
537
655
656
658
673
674
678
685
693
700
703
706
711
Grade
5, 5, 5, 4, 3
1, 1, 1,0,0
2, 2, 2, 1
4, 3, 3, 1,0
4,4,3,3, 1
3, 2, 2, 2, 2
5, 4, 3, 3, 3
5, 5, 4, 4, 4
4, 4, 4, 4, 4, 3
1, 0, 0, 0, 0, 0
3, 2, 2, 2, 2
5, 4, 4, 4, 4
4, 4, 4, 3, 2
4, 3, 3, 3
2, 2, 1, 1, 1
4, 4, 4, 4, 4
5, 5, 5, 5, 5, 5
5, 5, 5, 5, 5, 5
4, 4, 3, 3, 3
2, 2, 1, 1, 1
(mediian)
2
3
3
2
4
4
4
0
2
4
4
3
1
4
3
1
1 2 3 4 5
Figure 1 Silver stained gel electropherogram of NP40 extracts
of four primary mammary tumours of differing pulmonary
colonisation potentials.
Lane 1: Molecular weight markers (190K, 95K, 66.5K, 45K,
21.5 K, 16.9 K, 12.5 K in vertical order from top)
Lane 2: Tumour number 700 HCP
Lane 3: Tumour number 703 HCP
Lane 4: Tumour number 706 HCP
Lane 5: Tumour number 711 LCP
There are no consistent differences in protein composition
between tumours of differing colonisation potentials.
in their protein patterns on one- and two-dimensional gels
either from each other or from their corresponding primary
tumours.
Effiects of succini j-ConA and succinvl-WGA treatment
Saturation of the cell surface ligands of the 2 s-lectins was
achieved at 250,ugs-lectin 10- 6 cells with an incubation
period of I h, when -1 ,pg s-ConA was bound per 106 cells
or 0.5 ugs-WGA 10-6 cells (Figure 2). For s-ConA there was
considerable non-specific and non-releasable binding (i.e.
labelled lectin not released by excess of the specific sugar).
This differed from tumour to tumour between approximately
one-third and one-half of the total amount of s-ConA
bound. This was not so with s-WGA where both of these
factors were almost negligible.
The conditions chosen for treatment of the cells were
optimised to ensure saturation of the available binding sites
(see Materials and methods). Some agglutination was
occasionally noticed at the time of cell counting but this was
always minor and was also observed in the control cells-
presumably an effect of the incubation procedure rather than
of the s-lectins. There were no differences in percentage
viability between control and lectin-treated cell populations.
Table III shows that for the 9 tumours studied, the
coating of their cells with s-ConA or s-WGA did not
significantly or consistently alter the pulmonary colonisation
capability relative to untreated control cells from the same
tumour.
i
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Table 1II Effects of succinylated lectins on pulmonary colonisation
potentials of mouse mammary adenocarcinoma cells
s-WGA binding Tinour
no. s-ConA
(0)
839 1,0, 0,
s-WGA
(0)
2, 0, 0, 0
(4) (4)
848 2, 3, 4, 4, 4 2, 2, 4, 4, 4
0 50 100 150 200 250
B
(5)
850 5, 5, 4
(0)
860 0,0,0,0,
(1)
875 2, 2, 1, 1, 1, 1
(2)
873 3,2, 2, 2, 2
(4)
880 4,4,4,4,4,4
(3)
882 4, 4, 2, 0
(I)
893 5,5, 1,0,0
(5)
5, 5, 5, 5
(1)
2, 1, 1, 1, 0
(1)
2, 2, 1, 1, 1
(2)
4, 3, 2, 2, 2
(5)
5, 5, 5, 5, 4, 4
(2)
4, 3, 3, 2, 2, 2
(1)
5, 2, 1, 1, 1, 0
Control
(0)
2, 1,0,0, 0
(2)
2, 2, 3
(5)
5, 5
(0)
2, 0, 0, 0, 0, 0
(I)
1, 1, 1, 1,0
(2)
3, 2, 2, 2, 2, 1
(4)
5, 5,4, 4, 4, 4
(2)
4, 2, 2, 2, 1
(2)
4, 3, 2, 2, 2
Figures in parentheses aremedian colonisation grades foreach group.
1 2 3 M.W.
- 215k
-93k
0 50 100 150 200 250
Fig lectin applied
Figure 2 Typical plots of the binding of s-lectins to murine
mammary tumour cells in the presence of various concentrations
of s-lcctin.
A:
B:
x axis:
v axis:
*:
A:
A:
s-WGA binding
s-ConA binding
jig 12s1-s-lectin 10 -6 cells
ng 12-1-s-lectin bound to 106 cells (note that this axis in
B has double the range of that in A)
total binding
non-releasable binding
non-specific binding.
These cells were from tumour UST 817.
/fQetes of swiainsonine and tunicamjcin treatment
The autoradiograph (Figure 3) shows that swainsonine
treatment caused the appearance of a relatively low
molecular weight band heavily stained with 1251-ConA and a
slightly altered pattern of some bands compared with the
control lane. In the lane containing the NP-40 extract from
the tunicamycin treated cells there was a marked decrease in
the number of glycoproteins recognized by 125I-ConA. The
drugs were therefore clearly effective in influencing surface
glycoprotein composition under the conditions used.
The total number of cells surviving in culture flasks at the
end of the 3-day recovery period after 16h treatment with
swainsonine or tunicamycin was the same as that in controls
(Table IV). Therefore these agents were not detectably toxic
in VitlrO.
It can be seen in Table V that swainsonine also did not
affect the tumourigenicity of treated cells injected into s.c.
fat pads compared with untreated control cells. However the
tumourigeneicity of tunicamycin-treated cells was
substantially decreased.
The colonisation potentials of cells from different tumours
inoculated i.v. after treatment with swainsonine were no
- 67k
-44k
- 29k
- 14 k
Figure 3 Autoradiograph of a Western electroblot of NP40
extracts of a tumour cultured in the presence of: lane 1, no
addition (control); lane 2, swainsonine; lane 3, tunicamycin. All
tracks were loaded with equal amounts (50,ug) of total protein.
The blot was probed with 1251 ConA as described. Note the
diminution of lectin by proteins in track 3 compared to track
1. Also thc appearance of a low mol. wt band in track 2 (arrow)
shows accentuation of ConA binding to proteins with altered
glycosylation and indicates a high mannose content.
different from their controls; those of tunicamycin treated
cells were strikingly lower than their untreated counterparts
(Table VI).
Discussion
These results demonstrate that the capability of cells
competent to make metastatic colonies in the lungs after
vascular dissemination is extremely robust and can survive
quite gross interference with glycosylation patterns and
surface composition. The observations are supported by
those published earlier (Sargent et al., 1983) demonstrating
that vigorous digestion of surface components by various
enzymes did not have striking effects on colonisation
capability by similar murine mammary tumour cells. In the
current work the most marked effect on pulmonary
A
500
400
300
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-o
c
0
.0
c
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0)
c
1oo0
800
400
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Table IV Effect of swainsonine or tunicamycin treatment on survival of
mammary tumour cells in vitro
16h 40h
Tumour no. viability cellsml 1 viability cellsml -
rcontrol 85O% 1.7x 106 82% 1.Sx 106
962 swainsonine 85% 2.4 x 10' 77% 2.1 x 106
Ltunicamycin 76% 2.0 x 106 65% 1.3 x 106
rcontrol 80% 1.2 x 106 80% 1.4 x 106
986 swainsonine 89% 1.7 x 106 80% 1.8 x 106
Ltunicamycin 82% 1.4 x 106 68% 1.4 x 106
Table V The effects of tumicamycin and swainsonine on tumorigenicity
SWAINSONINE TUNICAMYCIN CONTROL
treatment treatment (no treatment)
(2) (2) (2)
Cumulated Cumulated Cumulated
(1) tumour (1) tumour (1) tumour
Tumour Minimum yield Minimum yield Minimum yield
identification tumourigenic (all cell tumourigenic (all cell tumourigenic (all cell
number dose doses) dose doses) dose doses)
972 i03 9/12 10' 5/12 i03 7/12
973 No tumours grew from this primary in any group of mice
1014 104 5/12 103 4/12 104 5/12
1016 No tumours grew from this primary in any group of mice
1017 105 1/12 NTG NTG NTG NTG
1020 104 2/12 NTG NTG 104 3/12
1022 No tumours grew from this primary in any group of mice
1023 105 1/12 NTG NTG 104 3/12
(1)=Minimum tumorigenic dose is the dose of viable cells to give a single tumour; (2) =Number of
tumours/number of sites injected; NTG = No tumours grew in this category.
Table VI Effects of swainsonine and tunicamycin on pulmonary colonisation
potential of mammary tumour cells
UST Swainsonine Tunicamycin Control
839 0,0,0,0,0,0 2,1,0,0,0
850 1,1,1,1,1,1 5,5
875 0,0,0,0,0,0 1,1,1,1,0
880 1,0,0,0,0 5,5,4,4,4,4
893 0,0,0,0,0,0 5,4,3,2,2,2
937 1,0,0,0,0,0 0,0,0,0,0,0
942 1,1,,1,0,0 2,2,1,1,0
948 0,0,0,0,0,0 2,1,1,0,0,0
951 1,1,1,0,0,0 4,4,3,0
954 1,0,0,0,0,0 4,2,1,0,0,0
996 0,1,2,2,3,3,4,5 2,2,2,4,5,5,5
1011 2,2,2,2,2,2,3 2,2,2,2,3,3,3,3
1012 0,0,0,0,0,0,1,1 0,0,0,0,1,1,1,1
1019 1,2,4,4,4,4,4,5 0,1,2,2,3,3,4,5
1025 0,0,0,1 0,0,0,0,0,1
colonisation was exerted by tunicamycin and these findings
therefore concur with those of Irimura and Nicolson (1982).
However, as the antibiotic also had a strong effect in
suppressing tumourigenicity of these mammary tumour cells
we cannot conclude that the suppression of pulmonary
colonisation capability is necessarily due to effects on surface
protein glycosylation. The decrease in tumourigenicity
without concomitant reduction in viability (at least in vitro)
is itself very interesting but separate from the problem under
study.
So far as metastatic colonisation is concerned these agents
were expected to have some effect, if surface glucosylation
pattern influences the process, because they all modify the
formation or presentation of glycosyl residues on the cell
surface. The modified lectins succinyl-ConA and succinyl-
WGA are divalent, non-toxic, non-agglutinating derivatives
of their native proteins, ConA and WGA (Gunther et al.,
1973 and Monsigny et al., 1979) which bind specifically to
the sugars mannose and N-acetyl glucosamine and could
thus coat or mask glycoproteins containing such residues.
Tunicamycin is an antibiotic which inhibits the
glycosylation of, (a) proteins by blocking the assembly of the
intermediate glycosylated dolichol phosphate, which, under
normal circumstances, would transfer the oligosaccharide
structure to a nascent protein for subsequent enzymic
processing to a mature form (Guarnaccia et al., 1983 and
references therein), and (b) gangliosides and glyco-
sphingolipids by preventing the carriage of nucleotide
sugars (UDP-gal and UDP-gal NAc) across the Golgi
membrane (Guarnaccia et al., 1983 and Yusuf et al., 1983).SURFACE GLYCOPROTEINS AND METASTASIS 27
Thus all glycosylation, except for 0-linked serine and
threonine glycosylation, is abolished.
Swainsonine is a more selective agent which inhibits the
activity of lysosomal and Golgi oc-mannosidase 1I (Schwarz
& Datema, 1984; Tulsiani et al., 1982; Elbein et al., 1982;
Arumughan & Tanzer, 1983; Danielsen et al., 1983; Cenci di
Bello et al., 1983; Gross et al., 1983; Winkler & Segal, 1984).
High mannose oligosaccharides are expressed at the cell
surface after treatment with this compound but terminal
glycosylation is not blocked.
It cannot be argued that these agents failed to influence
pulmonary colonisation because we did not use them in
appropriate conditions for them to exert an effect on the cell
surface. The data presented show that specific saturation
binding was achieved with the lectins, which were used in
succinylated form to avoid causing significant cellular
agglutination prior to inoculation* and the autoradiographs of
the extracts of swainsonine and tunicamycin treated cells
unequivocally demonstrate marked changes in surface glyco-
sylation patterns. The treated cells were kept at low
temperature until inoculation, which was always done within
an hour, but it is possible that internalisation of the surface
bound lectins or repair of glycosylated molecules in cells
treated with drugs could account for the absence of an
observable effect on experimental metastasis (such turnover
being more rapid at body temperature after reinoculation). If
so, the reserves of metastasising tumour cells for rapid repair
of their surfaces without impedence (or even observable
delay) of metastatic colonisation are impressive. In contrast,
lymphocytes treated with succinylated lectins or with various
enzymes were reported to have considerably altered patterns
of traffic in the body (Gallatin et al., 1983 and references
therein). It is therefore clear that cell surface modification by
treatment in vitro can persist long enough to alter cell
behaviour in vivo. This is endorsed by our finding of
reduction of pulmonary colonisation after treatment of the
tumour cells with tunicamycin.
It seems unlikely therefore that the rate of recovery of cell
surface composition of these mammary tumour cells after
various treatments would have been so fast as to not permit
detection of an effect on pulmonary colonisation. There are
several published accounts which demonstrate that recovery
of cell surface composition is not of the order of seconds but
takes hours or days. Also our own evidence, for example
with effects of tunicamycin on attachment to the substratum,
are in conformity with these estimates. The transfer of cells
to the pulmonary vasculature after i.v. injection takes only
seconds. Therefore, the cell surface modifications had the
opportunity to modulate colonisation after vascular release
but did not do so. We know that recovery takes place and
the main point is that short-term changes in cell surface
properties might either enable more tumour cells to slip
through the pulmonary circulation and thus alter the
distribution of secondary deposits, or make them remain
*Cellular agglutination can in some circumstances augment
pulmonary colonisation.
longer in the circulation and thus more subject to attrition
or make them more accessible to scavenging cells in the
blood and in various organs. In fact none of these things
happened and it would seem that further investigation of the
role of the cell surface in metastasis would best be
approached by introducing stable heritable changes into the
tumour cell population by genetic manipulation as these
would have more sustained effects.
The recent report that transfection of metastasis-
competent cells with the gene for an H-2 alloantigen resulted
in suppression of metastatic performance by the transfected
cell is of importance in this context (Wallich et al., 1985). It
demonstrates that the surface glycoprotein composition of
the disseminating tumour cells can elicit systemic responses
as well as affect short-range interactions between tumour
cells and adjacent normal cells during the formation of
metastatic deposits.
In conclusion, the evidence presented in this communi-
cation, taken in conjunction with that obtained in our work
on enzyme treatment of cell surfaces before reinoculation of
tumour cells, indicates that either the glycoprotein
composition of the surfaces of cells of these mammary
tumours does not particularly affect their ability to form
metastatic pulmonary colonies or that these tumour cells are
strikingly resilient to gross perturbation in membrane
composition and can still mobilise the complex sequence of
events involved in metastatic colonisation. Either way, it has
to be concluded that at least in this tumour system there is
as yet no decisive evidence that glycosylated components of
the cell surface significantly affect intrinsic metastatic
colonisation capability. As things stand at present, therefore,
the findings of this investigation have not been able to refute
the hypothesis that the differences in cell surface glyco-
protein composition between metastatic and non-metastatic
cells are merely concomitant associations of the metastatic
process and are not directly instrumental in it. Recent
reports (Shearman and Longenecker, 1981; Vollmers and
Birchmeier, 1983a, b; McGuireetal., 1984; Vollmers etal., 1984)
that metastatic capability of certain tumour cell lines is
diminished by monoclonal antibodies to cell surface
constituents suggests a new way in which decisive proof of
cell surface involvement in metastasis might be obtained.
Such approaches will however need to be able to show that
the tumour cells with surface bound antibodies are not
devitalised in ivo by immunological damage in the presence
of complement or made more subject to attack by the host
cellular immune system, because of the foreign protein
attached to their surfaces.
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